Appeal No. 2000-1682 Page 8 Application No. 08/845,503 Appellant’s specification also indicates that the precise length of the microprotrusions needed to disrupt the stratum corneum may vary from patient to patient because of differences in the thickness of the stratum corneum between patients and other surface characteristics of the patient’s skin and may also vary from delivery site to delivery site on the same patient (specification at page 7). As there are these differences in the thickness of the stratum corneum from patient to patient and from delivery site to delivery site on the same patient (specification at page 7), it is our view that for at least some patients the microprotrusions of Gerstel would be capable of cutting into the underlying epidermis, which is all that apparatus claim 1 requires. We note that Gerstel does not seem to disclose blades of elongated cross section. However, appellant does not argue this as a difference and thus it will be assumed that this limitation is met by Gerstel. Cf In re Baxter Travenol Labs, 952 F.2d 388, 391, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991)(“It is not the function of this court to examine the claims in greater detail than argued by an appellant, looking forPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007